Trade 3SBio Inc. - 1530 CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.10 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.021452% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.000466% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 10 | ||||||||
| Currency | HKD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | Hong Kong | ||||||||
| Commission on trade | 0% |
| Prev. Close | 13.3 |
| Open | 13.8 |
| 1-Year Change | 142.11% |
| Day's Range | 12.8 - 13.8 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 25, 2025 | 12.90 | -0.65 | -4.80% | 13.55 | 13.90 | 12.80 |
| Apr 24, 2025 | 13.30 | 0.55 | 4.31% | 12.75 | 13.55 | 12.70 |
| Apr 23, 2025 | 12.75 | -0.50 | -3.77% | 13.25 | 13.70 | 12.45 |
| Apr 22, 2025 | 12.50 | 0.00 | 0.00% | 12.50 | 12.90 | 12.00 |
| Apr 17, 2025 | 11.90 | 0.10 | 0.85% | 11.80 | 12.05 | 11.65 |
| Apr 16, 2025 | 11.95 | -0.45 | -3.63% | 12.40 | 12.50 | 11.60 |
| Apr 15, 2025 | 12.45 | -0.60 | -4.60% | 13.05 | 13.10 | 12.40 |
| Apr 14, 2025 | 12.80 | 0.05 | 0.39% | 12.75 | 13.40 | 12.50 |
| Apr 11, 2025 | 12.35 | 0.85 | 7.39% | 11.50 | 12.70 | 11.25 |
| Apr 10, 2025 | 11.70 | -0.10 | -0.85% | 11.80 | 13.05 | 11.65 |
| Apr 9, 2025 | 11.25 | 0.80 | 7.66% | 10.45 | 11.45 | 9.95 |
| Apr 8, 2025 | 11.15 | 0.80 | 7.73% | 10.35 | 11.25 | 10.30 |
| Apr 7, 2025 | 9.95 | -1.35 | -11.95% | 11.30 | 11.35 | 9.95 |
| Apr 3, 2025 | 13.20 | 0.50 | 3.94% | 12.70 | 13.65 | 12.45 |
| Apr 2, 2025 | 12.90 | -0.05 | -0.39% | 12.95 | 13.35 | 12.60 |
| Apr 1, 2025 | 13.00 | 1.10 | 9.24% | 11.90 | 13.40 | 11.90 |
| Mar 31, 2025 | 11.90 | 0.00 | 0.00% | 11.90 | 12.50 | 11.65 |
| Mar 28, 2025 | 12.20 | -0.10 | -0.81% | 12.30 | 13.00 | 11.90 |
| Mar 27, 2025 | 11.95 | 1.20 | 11.16% | 10.75 | 12.35 | 10.50 |
| Mar 26, 2025 | 10.85 | 1.20 | 12.44% | 9.65 | 10.95 | 9.65 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
3SBio Company profile
3SBio Inc. develops, manufactures, markets, and sells biopharmaceuticals. The company's primary products include TPIAO, a recombinant human thrombopoietin for thrombocytopenia; Yisaipu, a tumour necrosis factor for treating rheumatoid arthritis, ankylosing spondylitis, and psoriasis; and EPIAO, a recombinant human erythropoietin for the treatment of anemia associated with chronic kidney disease (CKD), chemotherapy-induced anemia, and reduction of allogeneic blood transfusion in surgery patients. Its primary products also comprise SEPO, a recombinant human erythropoietin for anemia associated with CKD and chemotherapy; Byetta/Bydureon, an exenatide injection to improve glycemic control in adults with type-2 diabetes mellitus; and Qiming Keli for retinopathy caused by type-2 diabetes. In addition, the company offers Ruisiyi to treat advanced breast cancer; Wanwei for treating vomiting caused by cytotoxic chemotherapy; and Intefen to treat lymphatic or hematopoietic malignancies and viral infections. Further, it provides Inleusin for renal cell carcinoma, melanoma, thoracic fluid build-up caused by cancer, and tuberculosis; Etanercept for moderate to severe rheumatoid arthritis and plaque psoriasis, and active ankylosing spondylitis; and Sparin for prophylaxis and vein thrombosis, and to prevent clotting during hemodialysis. Additionally, the company offers Mandi for male-pattern alopecia and alopecia areata; Aiyishu for iron-deficiency anemia; Disu to prevent and treat chronic bronchitis, colds, and asthma; Jiannipai to prevent acute rejection after renal transplantation; and Humulin for diabetes, as well as contract development and manufacturing, trading, project management and consultation, and technology services. The company markets its products through in-house sales and marketing team, as well as distributors and third-party promoters. 3SBio Inc. was incorporated in 2006 and is headquartered in Shenyang, the People's Republic of China.| Industry: | Biopharmaceuticals |
瀋陽經濟技術開發區十號路1甲3號
SHENYANG
LIAONING
CN
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com